BMSSC
BMY icon

B. Metzler seel. Sohn & Co’s Bristol-Myers Squibb BMY Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.37M Buy
105,037
+139
+0.1% +$8.1K 0.06% 181
2025
Q4 		$5.66M Sell
104,898
-7,081
-6% -$341K 0.05% 194
2025
Q3 		$5.05M Sell
111,979
-44,554
-28% -$2.08M 0.04% 201
2025
Q2 		$7.25M Sell
156,533
-3,542
-2% -$174K 0.07% 145
2025
Q1 		$9.76M Buy
160,075
+81,276
+103% +$4.74M 0.1% 105
2024
Q4 		$4.46M Buy
78,799
+1,305
+2% +$72.9K 0.05% 188
2024
Q3 		$4.01M Buy
77,494
+218
+0.3% +$10.2K 0.04% 234
2024
Q2 		$3.21M Sell
77,276
-1,673
-2% -$74.9K 0.03% 262
2024
Q1 		$4.27M Sell
78,949
-55,214
-41% -$2.81M 0.05% 219
2023
Q4 		$6.88M Sell
134,163
-76,610
-36% -$4.02M 0.09% 133
2023
Q3 		$12.2M Sell
210,773
-96,878
-31% -$5.94M 0.18% 70
2023
Q2 		$19.7M Buy
307,651
+59,567
+24% +$3.99M 0.27% 54
2023
Q1 		$17.2M Sell
248,084
-104,932
-30% -$7.4M 0.27% 61
2022
Q4 		$25.4M Sell
353,016
-20,543
-5% -$1.55M 0.43% 44
2022
Q3 		$26.6M Sell
373,559
-1,597,689
-81% -$116M 0.48% 40
2022
Q2 		$152M Sell
1,971,248
-425,827
-18% -$32.4M 2.49% 10
2022
Q1 		$175M Buy
2,397,075
+26,426
+1% +$1.77M 2.35% 9
2021
Q4 		$148M Buy
2,370,649
+149,227
+7% +$8.75M 1.93% 13
2021
Q3 		$132M Sell
2,221,422
-686,131
-24% -$45.2M 1.91% 14
2021
Q2 		$194M Buy
2,907,553
+250,345
+9% +$16.3M 2.89% 9
2021
Q1 		$168M Buy
2,657,208
+614,429
+30% +$38.2M 2.76% 10
2020
Q4 		$127M Buy
+2,042,779
New +$126M 2.36% 11

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

B. Metzler seel. Sohn & Co's BMY Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co increased its Bristol-Myers Squibb (BMY) stake by 0.13% in Q1 2026, buying an estimated $8.1K and bringing the position to 105,037 shares worth $6.37M. The position accounts for 0.06% of the portfolio, ranked #181.

B. Metzler seel. Sohn & Co first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $194M in Q2 2021. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 105,037 shares of Bristol-Myers Squibb worth $6.37M as of Q1 2026.
  • B. Metzler seel. Sohn & Co bought 139 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.1K.
  • Bristol-Myers Squibb made up 0.06% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #181 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • B. Metzler seel. Sohn & Co's Bristol-Myers Squibb position peaked at $194M in Q2 2021.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.